7.4 Post-Treatment Evaluation, Hemostasis Management, and Discharge Safety
Key Takeaways
- The post-dialysis rinse-back sequence requires reducing blood pump flow to 150–200 mL/min, utilizing minimal normal saline (typically 200–250 mL), and maintaining continuous observation of the venous drip chamber to avoid microbubble infusion.
- Hemostasis must be achieved via light, non-occlusive two-finger manual digital compression over both the external cutaneous puncture and internal vascular wall puncture tracts for 10–15 minutes while continuously feeling a thrill.
- Mechanical hemostatic clamps and circular extremity bandaging are strictly prohibited because unmonitored compression halts luminal blood flow, causing intimal damage and acute vascular access thrombosis.
- Post-treatment discharge criteria require assessing sitting and standing vital signs for orthostatic hypotension, verifying target weight against Estimated Dry Weight (EDW), confirming complete hemostasis, and enforcing wheelchair transport for unstable patients.
7.4 Post-Treatment Evaluation, Hemostasis Management, and Discharge Safety
Clinical Core: The conclusion of a hemodialysis treatment is a high-risk transition phase. Improper rinse-back technique can introduce fatal air emboli or volume overload; incorrect needle removal or compression can destroy an arteriovenous fistula through acute thrombosis; and premature discharge without orthostatic vital sign assessment can lead to catastrophic syncopal falls and head trauma. Advanced technicians must execute post-dialysis evaluation and hemostasis with strict technical discipline.
Extracorporeal Circuit Termination & Rinse-Back Sequence
Terminating hemodialysis requires returning the patient's blood safely from the extracorporeal circuit while preventing air entry and fluid overload:
[Step 1] Turn Ultrafiltration OFF → Verify Total UF Volume Achieved
│
[Step 2] Reduce Blood Pump Flow (Qb) to 150–200 mL/min
│
[Step 3] Clamp Arterial Access Line & Attach Arterial Tubing to Saline Source
│
[Step 4] Open Saline Clamp & Run Blood Pump to Return Blood through Dialyzer
│
[Step 5] Monitor Venous Drip Chamber & Optical Air Detector Continuously
│
[Step 6] Stop Blood Pump Precisely as Clearing Fluid Reaches Venous Connection
│
[Step 7] Clamp Venous Bloodline & Venous Fistula Needle Tubing Aseptically
Critical Technical Considerations During Rinse-Back
- Blood Pump Speed: Always reduce blood flow ($Q_b$) to 150 to 200 mL/min before initiating rinse-back. Pumping saline at high speeds ($>300\text{ mL/min}$) increases circuit pressures, impairs visualization of the clearing front, and risks rapidly driving air past the optical detector.
- Saline Volume Discipline: Administer only the volume of sterile normal saline (0.9% NaCl) required to clear the circuit—typically 200 to 250 mL. Pushing excessive saline (e.g., 400–500 mL) to make the lines "crystal clear" directly counteracts the ultrafiltration achieved during the session and contributes to post-dialysis fluid overload and interdialytic hypertension.
- Microbubble Prevention: Maintain the fluid level in the venous drip chamber at its designated fill line throughout rinse-back. Never allow the saline bag to run dry while connected to the pump, and never bypass the machine's ultrasonic or optical air detectors.
Needle Removal Mechanics and Hemostasis Management
Preserving vascular access longevity requires correct needle withdrawal mechanics and post-dialysis manual compression:
1. Pre-Withdrawal Safety Rule
- NEVER remove access needles while the blood pump is operating. The blood pump must be fully stopped, bloodlines clamped, and the patient disconnected from the extracorporeal circuit before needle extraction. Removing needles while under pump operation causes massive external hemorrhage, air entrainment, and severe biohazard blood spraying.
2. Needle Withdrawal Technique
- Angle of Extraction: Withdraw each needle at the exact same angle at which it was inserted—typically 20° to 35° for an arteriovenous fistula (AVF) and 45° for an arteriovenous graft (AVG).
- The Cutting Bevel Hazard: DO NOT apply pressure over the insertion site while the needle is being withdrawn. Applying downward force while pulling the needle drags the sharp, cutting bevel against the interior endothelial lining of the vessel, slicing the vein wall like a surgical scalpel. This enlarges the puncture defect, causes subcutaneous extravasation, accelerates pseudoaneurysm formation, and induces intimal hyperplasia. Apply pressure only after the needle has completely cleared the skin surface.
3. The Two-Finger Manual Digital Compression Technique
Because cannulation needles enter the skin and vessel at an angle, the external cutaneous puncture site and the internal vascular wall puncture site are anatomically separated by 0.5 to 1.0 cm:
Finger 1 (Cutaneous Site) Finger 2 (Internal Vessel Hole)
▼ ▼
Skin: ────────[Skin Hole]───────────────────────────
\ (Angled Needle Track 0.5–1.0 cm)
Vessel Wall: ───────\───────[Vessel Hole]───────────
Vessel Lumen: ══════════════════════════════════════ (Maintain Thrill!)
- Two-Finger Placement: Place two gloved fingers over folded sterile gauze pads. Place the distal finger directly over the visible external skin puncture, and place the proximal finger approximately 0.5 to 1.0 cm higher along the course of the vessel tract over the internal vascular entry hole.
- Pressure Modulation (Preserving the Thrill): Apply light to moderate digital pressure sufficient to stop blood from exiting the puncture tracts. A continuous thrill or pulsatile blood flow MUST remain palpable beneath or immediately adjacent to the compressing fingers throughout the entire hold. If the thrill disappears, the technician is pressing too hard and has completely occluded luminal blood flow.
- Compression Duration: Maintain continuous, uninterrupted manual pressure for a minimum of 10 to 15 minutes. Never "peek" or lift the gauze before 10 minutes have elapsed, as lifting the pad disrupts early platelet aggregation and fibrin clot formation, resetting the clotting cascade.
4. Dangers of Mechanical Clamps and Circular Bandaging
| Practice | Clinical Risk & Pathophysiology | Regulatory / Practice Standard |
|---|---|---|
| Mechanical Access Clamps (C-Clamps / Spring Clamps) | Apply unyielding, unmonitored mechanical force that flattens the vessel wall, causing intimal tears, blood stasis, and acute access thrombosis. | Strictly prohibited or strongly discouraged by KDOQI and CMS Conditions for Coverage. |
| Circular (Circumferential) Bandaging | Wrapping tape completely around the extremity creates a venous tourniquet, obstructing venous outflow and causing acute engorgement, ischemia, and thrombosis. | Strictly prohibited. Only apply sterile gauze secured with independent, non-circumferential tape strips. |
| Automated Pressure Dressings | Excess tension compresses the access lumen over time as post-treatment tissue edema develops. | Prohibited. Patients must never leave with rigid, constrictive dressings. |
Post-Dialysis Clinical Assessment and Fluid Balance
Before a patient is cleared for discharge, the clinical technician must obtain and evaluate comprehensive post-treatment parameters:
1. Orthostatic Vital Sign Measurement
- Measure and record sitting blood pressure and pulse, followed immediately by standing blood pressure and pulse after the patient has stood for 1 to 3 minutes (measured on the non-access arm).
- Diagnostic Criteria for Orthostatic Hypotension:
- A decrease in systolic blood pressure of ≥20 mm Hg, OR
- A decrease in diastolic blood pressure of ≥10 mm Hg, within 3 minutes of standing.
- If orthostasis or dizziness is detected, seat the patient immediately, alert the RN, and re-evaluate hemodynamic recovery. Never permit an orthostatic patient to ambulate unassisted.
2. Weight Assessment Against Estimated Dry Weight (EDW)
- Weigh the patient on the clinic's calibrated scale, ensuring identical conditions to pre-treatment weighing (same shoes, outerwear removed, empty drainage bags, identical wheelchair/walker tare).
- Post-Weight > EDW (Under-Ultrafiltration): Indicates residual fluid overload. The patient remains hypervolemic, increasing the risk of interdialytic hypertension, nocturnal dyspnea, left ventricular strain, and acute pulmonary edema.
- Post-Weight < EDW (Over-Ultrafiltration): Indicates the patient was dialyzed below their true physiological dry weight. The patient is at high risk for delayed vascular collapse, severe post-dialysis muscle cramps, profound fatigue, permanent loss of residual kidney function, and access thrombosis from hemoconcentration.
Discharge Safety Criteria, Complications, and Patient Education
Outpatient hemodialysis facilities must enforce strict discharge criteria before releasing patients into the community:
Mandatory Discharge Criteria
- Hemostasis Complete: Bleeding from all cannulation puncture sites has ceased completely for at least 5 minutes prior to applying final sterile dressings. Clean, dry adhesive bandages applied without circumferential tension.
- Hemodynamic Stability: Standing systolic blood pressure $>100\text{ mm Hg}$ (or within physician-ordered parameters) without lightheadedness, nausea, diaphoresis, or dizziness.
- Vascular Access Patency: Auscultate a continuous low-pitched bruit and palpate a soft, continuous thrill throughout the access.
- Mental Clarity & Mobility: Patient is alert, oriented to person, place, and time, and demonstrates steady gait or is transferred safely via wheelchair.
Management of Post-Dialysis Complications
- Prolonged Bleeding (>20–30 Minutes): If bleeding persists despite 20 minutes of continuous manual pressure, alert the RN immediately. The RN will evaluate for heparin rebound, severe hypertension, or underlying venous outflow stenosis (which generates high intragraft/intrafistula hydrostatic pressure that blows clots off puncture sites). The RN may obtain orders for topical hemostatic agents (e.g., collagen pads, thrombin) or protamine sulfate.
- Post-Dialysis Fatigue ("Dialysis Washout"): Profound exhaustion occurring after dialysis resulting from rapid osmolar shifts, transient cerebral hypoperfusion, and cytokine activation. Advise patients to rest, avoid sudden postural changes, and report episodes lasting $>6$ hours to the care team.
- Wheelchair Transport Protocol: Patients who are frail, elderly, diabetic with neuropathy, or who experienced intradialytic hypotension must be escorted to the facility lobby or vehicle via wheelchair to prevent falls.
Patient Home Care Education
- Bandage Removal: Instruct the patient to remove the puncture site adhesive dressings in 4 to 6 hours. Leaving wet or soiled bandages on access sites overnight significantly increases the risk of serious bacterial infections.
- Activity Restrictions: Avoid lifting heavy objects (>10–15 lbs), carrying children or groceries on the access arm, wearing tight watches or restrictive clothing, or sleeping with the access arm bent or compressed under the head/body.
- Daily Access Monitoring: Educate the patient to palpate the thrill ("feel the buzz") and listen for the bruit daily upon waking and before bed. If the thrill is absent, contact the dialysis clinic or vascular surgeon immediately.
- Emergency Bleeding Protocol at Home:
- Place two fingers over clean gauze and apply firm, direct digital pressure directly over the bleeding site.
- Elevate the access extremity above heart level if possible.
- If bleeding does not stop within 15 to 20 minutes, or if pulsatile bleeding sprays from the site, maintain continuous pressure and call 911 immediately.
Following the discontinuation of hemodialysis, what is the clinically correct technique for achieving hemostasis at an arteriovenous fistula cannulation site?
Why are mechanical hemostatic clamps and circumferential extremity wrapping strongly discouraged or strictly prohibited by clinical practice standards for post-dialysis access care?
Prior to discharging an outpatient following hemodialysis, the technician measures a sitting blood pressure of 118/74 mm Hg and a standing blood pressure of 90/58 mm Hg. The patient states, 'I feel a little unsteady, but my ride is waiting outside.' What is the mandatory clinical action?